2012 DEC 17 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Research findings on Immune System Diseases and Conditions are discussed in a new report. According to news reporting out of Boston, Massachusetts, by NewsRx editors, research stated, "Syphilis is a chronic inflammatory disease caused by the sexually transmitted pathogen, Treponema pallidum. Concomitant HIV and syphilis infections are prevalent among men who have sex with men (MSM)."
Our news journalists obtained a quote from the research from Harvard University, "Syphilis negatively impacts disease management in the HIV-infected host by causing substantial immune activation, as evidenced by precipitous declines of CD4+ cells and by increased levels of HIV RNA. Syphilis has also been reported as a risk factor for hepatitis C virus (HCV) acquisition among MSM. Whether intercurrent syphilis has any negative impact on HCV treatment response is unknown."
According to the news editors, the research concluded: "This case report proposes that active symphilis infection may have been a key contributor to the patient's slow virologic response to his initial course of HCV treatment."
For more information on this research see: Syphilis negatively influences the response to hepatitis C virus treatment in an HIV-infected patient. Topics In Antiviral Medicine, 2012;20(4):134-8 (see also Immune System Diseases and Conditions).
Our news journalists report that additional information may be obtained by contacting E.H. Nagami, Harvard University Center for AIDS Research, Boston, MA, United States.
Keywords for this news article include: HCV, Boston, HIV/AIDS, Syphilis, Virology, Hepatology, RNA Viruses, Retroviridae, Massachusetts, United States, HIV Infections, Liver Diseases, Gastroenterology, Hepatitis C Virus, Infectious Disease, Vertebrate Viruses, Primate Lentiviruses, Flaviviridae Infections, Opportunistic Infections, North and Central America.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2012, NewsRx LLC